Constarium
← Search

Data · dataset · 2026

QUB-1942: a bioactive peptide from Phyllomedusa hypochodrialis skin secretion

Listed in ZivaHub and Deakin Research Online and DMU Figshare and UCL Research Data Repository — shown once because both records carry DOI 10.17034/32633352.v1

Antimicrobial peptides, separated and identified from frog and toad skin secretions, have been studied for years.

Description

In this thesis, QUB-1942, a peptide belonging to the phylloseptin family, was derived from the skin secretion of the orange-legged leaf frog, Phyllomedusa hypochondrialis. The peptide sequence was obtained through ‘shotgun’ cloning by constructing a cDNA library using frog skin secretion isolated mRNA.

The peptide was then synthesised by solid-phase peptide synthesis, purified by reversed-phase high-performance liquid chromatography, and structural-confirmed by matrix-assisted, laser desorption, ionisation, time-of-flight mass spectrometry. In bioassays, QUB-1942 showed inhibitory effects on the Gram-positive bacterium, Staphylococcus aureus (S. aureus ATCC CRM6538)at a concentration from 2 μM, the Gram-negative bacterium, Escherichia coli (E. coli ATCC CRM8739) at a concentration from 8 μM, and the yeast, Candida albicans (C. albicans ATCC CRM10231) at a concentration 64 μM. The minimum inhibitory concentration (MIC) value of the three microbes are 4 μM , 8 μM, 64 μM, respectively.

Read the rest (1 more)

In terms of MTT anticancer cell proliferation assay, QUB-1942 was proven to have anti-proliferative activity against a human lung cancer cell line (H838) in a range of concentrations from 10-6 M to 10-4 M. The trypan blue exclusion assay confirmed the killing effect of the peptide on H838 cells. However, QUB-1942 had a haemolytic effect higher than 20% on horse red blood cells when the concentration was higher than 64 μM. In conclusion, QUB-1942 has potential to become a safe antimicrobial and anticancer drug in the future after its haemolytic toxicity at high concentrations can be substantially decreased through structural modification.<br><br><i>Thesis embargoed until 31 December 2027</i>

Links

Where it is published

Catalogue records · 1

Topics

Inferred from text
Cancer 75% · Mass spectrometry 75%
Provenance · 4 source records, 11 field assertions
SourceKeyLast seenRaw
ZivaHuboai:figshare.com:article/3263335211 d agoJSON v1
Deakin Research Onlineoai:figshare.com:article/3263335211 d agoJSON v1
DMU Figshareoai:figshare.com:article/3263335211 d agoJSON v1
UCL Research Data Repositoryoai:figshare.com:article/3263335211 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[disease].local:disease:cancerenrichment · zivahub uct ac zakeyword-concept-rules@1.0.0title+description (75%)
concepts[field].local:field:earth-environmentalmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:earth-environmentalmapping · dro deakin edu auconnector:dro_deakin_edu_au@1.0.0
concepts[field].local:field:earth-environmentalmapping · figshare dmu ac ukconnector:figshare_dmu_ac_uk@1.0.0
concepts[field].local:field:earth-environmentalmapping · rdr ucl ac ukconnector:rdr_ucl_ac_uk@1.0.0
concepts[modality].local:modality:mass-spectrometryenrichment · zivahub uct ac zakeyword-concept-rules@1.0.0title+description (75%)
descriptionsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/description
license_textsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
publication_datesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
titlesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/title